Solid Biosciences Inc.

NasdaqGS:SLDB 주식 보고서

시가총액: US$221.9m

Solid Biosciences 미래 성장

Future 기준 확인 0/6

Solid Biosciences's earnings are forecast to decline at 9.1% per annum while its annual revenue is expected to grow at 76% per year. EPS is expected to grow by 10% per annum.

주요 정보

-9.1%

수익 성장률

10.0%

EPS 성장률

Biotechs 수익 성장27.1%
매출 성장률76.0%
향후 자기자본 수익률n/a
애널리스트 커버리지

Good

마지막 업데이트24 Oct 2024

최근 미래 성장 업데이트

Recent updates

We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth

Jul 26
We Think Solid Biosciences (NASDAQ:SLDB) Can Afford To Drive Business Growth

Buy Solid Biosciences: Unpacking Its Main Value Driver

Apr 10

Solid Biosciences: DMD Treatment Advancement With Next-Generation Capsid

Jan 17

Solid Biosciences to acquire gene therapy company AavantiBio

Sep 30

Analysts Have Lowered Expectations For Solid Biosciences Inc. (NASDAQ:SLDB) After Its Latest Results

Apr 30
Analysts Have Lowered Expectations For Solid Biosciences Inc. (NASDAQ:SLDB) After Its Latest Results

Some Analysts Just Cut Their Solid Biosciences Inc. (NASDAQ:SLDB) Estimates

Apr 28
Some Analysts Just Cut Their Solid Biosciences Inc. (NASDAQ:SLDB) Estimates

We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

Mar 17
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

Solid Biosciences (NASDAQ:SLDB) Is In A Good Position To Deliver On Growth Plans

Oct 28
Solid Biosciences (NASDAQ:SLDB) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

Jul 13
We're Not Very Worried About Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate

We're Hopeful That Solid Biosciences (NASDAQ:SLDB) Will Use Its Cash Wisely

Mar 17
We're Hopeful That Solid Biosciences (NASDAQ:SLDB) Will Use Its Cash Wisely

Soild Bio sinks 13% after Sarepta data misses goal

Jan 08

Solid Biosciences launches $90M private placement

Dec 11

Solid Biosciences: Does Not Look Like A Solid Investment Given Its Unsatisfactory Trial Data

Nov 10

수익 및 매출 성장 예측

NasdaqGS:SLDB - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026N/A-157-214-1945
12/31/2025N/A-122-111-1087
12/31/2024N/A-105-50-477
6/30/2024N/A-91-86-85N/A
3/31/2024N/A-90-93-91N/A
12/31/2023N/A-96-96-94N/A
9/30/2023N/A-91-110-108N/A
6/30/2023N/A-90-113-110N/A
3/31/20236-91-102-99N/A
12/31/20228-86-101-98N/A
9/30/202211-89-87-84N/A
6/30/202215-87-85-82N/A
3/31/202212-81-85-84N/A
12/31/202114-72-79-78N/A
9/30/202110-75-56-56N/A
6/30/20217-78-53-53N/A
3/31/20213-78-49-49N/A
12/31/2020N/A-88-57-57N/A
9/30/2020N/A-99-81-79N/A
6/30/2020N/A-107-85-83N/A
3/31/2020N/A-114-99-96N/A
12/31/2019N/A-117-97-93N/A
9/30/2019N/A-107-98-93N/A
6/30/2019N/A-97-96-89N/A
3/31/2019N/A-89-88-79N/A
12/31/2018N/A-75-78-70N/A
9/30/2018N/A-67-69-63N/A
6/30/2018N/A-62-63-57N/A
3/31/2018N/A-55N/A-50N/A
12/31/2017N/A-39N/A-43N/A
9/30/2017N/A-29N/A-35N/A
12/31/2016N/A-17N/A-20N/A

애널리스트 미래 성장 예측

수입 대 저축률: SLDB is forecast to remain unprofitable over the next 3 years.

수익 vs 시장: SLDB is forecast to remain unprofitable over the next 3 years.

고성장 수익: SLDB is forecast to remain unprofitable over the next 3 years.

수익 대 시장: SLDB is forecast to have no revenue next year.

고성장 수익: SLDB is forecast to have no revenue next year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if SLDB's Return on Equity is forecast to be high in 3 years time


성장 기업 발견